ROYALTY PHARMA PLC shareholders Q2 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 317 filers reported holding ROYALTY PHARMA PLC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.4%.

ROYALTY PHARMA PLC shareholders Q2 2023
NameSharesValueWeighting ↓
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1,914,216$58,8430.07%
FOX RUN MANAGEMENT, L.L.C. 7,750$238,2350.07%
Cubist Systematic Strategies, LLC 330,068$10,146,2930.07%
Schonfeld Strategic Advisors LLC 249,477$7,668,9220.07%
Silicon Valley Community Foundation 16,725,265$544,0880.06%
Virtu Financial LLC 26,636$8190.06%
Petrus Trust Company, LTA 17,714$544,5280.06%
State of Wyoming 6,418$197,2890.06%
China Universal Asset Management Co., Ltd. 5,874$1810.06%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 382,729$11,765,0890.06%
Man Group plc 578,053$17,769,3500.06%
JUPITER ASSET MANAGEMENT LTD 163,200$5,013,5040.06%
Campbell & CO Investment Adviser LLC 9,970$306,4780.06%
PGGM Investments 107,487$3,3040.05%
Ensign Peak Advisors, Inc 842,540$25,899,6800.05%
Bank Pictet & Cie (Europe) AG 50,000$1,537,0000.05%
Quantbot Technologies LP 25,626$787,7430.05%
Tidal Investments LLC 56,598$1,7400.05%
Mendota Financial Group, LLC 1,441$44,2970.05%
Tredje AP-fonden 112,053$3,444,5090.05%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q2 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.